新型冠状病毒肺炎与癌症患者。
COVID-19 in the Cancer Patient.
机构信息
From the Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Anesthesiology and Pain Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
出版信息
Anesth Analg. 2020 Jul;131(1):16-23. doi: 10.1213/ANE.0000000000004884.
Abstract
The novel coronavirus disease 2019 (COVID-19) was first reported in China in December 2019. Since then, it has spread across the world to become one of the most serious life-threatening pandemics since the influenza pandemic of 1918. This review article will focus on the specific risks and nuanced considerations of COVID-19 in the cancer patient. Important perioperative management recommendations during this outbreak are emphasized, in addition to discussion of current treatment techniques and strategies available in the battle against COVID-19.
摘要
2019 年新型冠状病毒病（COVID-19）于 2019 年 12 月在中国首次报告。自那时以来，它已在全球范围内传播，成为自 1918 年流感大流行以来最严重的威胁生命的大流行之一。本文将重点介绍癌症患者 COVID-19 的具体风险和细微考虑因素。除了讨论目前针对 COVID-19 的治疗技术和策略外，还强调了在此次疫情期间的重要围手术期管理建议。
相似文献
1
COVID-19 in the Cancer Patient.新型冠状病毒肺炎与癌症患者。
Anesth Analg. 2020 Jul;131(1):16-23. doi: 10.1213/ANE.0000000000004884.
2
Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic.为肿瘤临床医生制定以患者为中心的框架，以应对 COVID-19 大流行期间癌症护理中的不确定性。
Curr Treat Options Oncol. 2020 Oct 29;21(12):99. doi: 10.1007/s11864-020-00795-z.
3
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.2019冠状病毒病（COVID-19）与免疫参与性癌症治疗
JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.
4
Effect of the COVID-19 pandemic on cancer treatment and research.2019冠状病毒病大流行对癌症治疗及研究的影响。
Lancet Haematol. 2020 Jun;7(6):e432-e435. doi: 10.1016/S2352-3026(20)30123-X. Epub 2020 Apr 24.
5
Palliative Care for Patients With Cancer in the COVID-19 Era.新冠疫情时代癌症患者的姑息治疗
JAMA Oncol. 2020 Oct 1;6(10):1527-1528. doi: 10.1001/jamaoncol.2020.1938.
6
Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection.2019年新型冠状病毒感染疫情期间小儿癌症的治疗临床策略。
Pediatr Blood Cancer. 2020 May;67(5):e28248. doi: 10.1002/pbc.28248. Epub 2020 Mar 8.
7
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic.COVID-19 疫情期间肺癌患者的个体化治疗建议和常见不良反应处理。
Thorac Cancer. 2020 Jun;11(6):1752-1757. doi: 10.1111/1759-7714.13424. Epub 2020 Apr 14.
8
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.COVID-19大流行期间的肿瘤护理服务：研究创新与结果的契机。
JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.
9
Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.癌症患者合并SARS-CoV-2感染的发热性中性粒细胞减少症的管理
JCO Oncol Pract. 2020 Jun;16(6):348-349. doi: 10.1200/OP.20.00197. Epub 2020 May 5.
10
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.面对新冠疫情时胃肠道肿瘤学的实践调整：肿瘤学专家关于将患者风险降至最低的建议
JCO Oncol Pract. 2020 Jul;16(7):383-388. doi: 10.1200/OP.20.00239. Epub 2020 Apr 30.
引用本文的文献
1
Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits.芬太尼在癌症疼痛管理中的应用：避免仓促判断并识别其潜在益处。
Drugs Context. 2023 Dec 14;12. doi: 10.7573/dic.2023-10-2. eCollection 2023.
2
Comparing COVID-19 Response Behaviors between a Cancer Patient Sample and a Population-Based Cancer-Free Sample in a Rural Midwestern State.比较中西部农村地区癌症患者样本和基于人群的无癌症样本在 COVID-19 应对行为方面的差异。
Oncology. 2023;101(12):808-816. doi: 10.1159/000533408. Epub 2023 Aug 14.
3
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.描绘严重急性呼吸综合征冠状病毒2（SARS-CoV-2）诱导的宿主免疫系统与DNA损伤反应网络之间的相互作用
Vaccines (Basel). 2022 Oct 20;10(10):1764. doi: 10.3390/vaccines10101764.
4
Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?评估脂溶性维生素补充剂对感染SARS-CoV-2的自身免疫性疾病患者和癌症患者的风险效益比：是否存在维生素与药物的相互作用？
Life (Basel). 2022 Oct 20;12(10):1654. doi: 10.3390/life12101654.
5
Perioperative corneal injury: An unseen casualty of COVID-19.围手术期角膜损伤：COVID-19的一个未被察觉的受害者。
JOJ Ophthalmol. 2022 Apr;9(2). doi: 10.19080/jojo.2022.09.555757. Epub 2022 Apr 26.
6
Aspects of Psychiatric Comorbidities in Breast Cancer Patients in Tertiary Hospitals Due to COVID-19 Outbreak in South Korea: A Single Center Longitudinal Cohort Study.由于韩国 COVID-19 疫情爆发，三级医院乳腺癌患者的精神共病相关因素：一项单中心纵向队列研究。
Medicina (Kaunas). 2022 Apr 19;58(5):560. doi: 10.3390/medicina58050560.
7
Impact of the COVID-19 Pandemic on Oncology Patients' Mental Health and Treatment Plans.新冠疫情对肿瘤患者心理健康及治疗计划的影响
Healthcare (Basel). 2022 Apr 29;10(5):825. doi: 10.3390/healthcare10050825.
8
Hematologic malignancies and COVID-19 infection: A monocenter retrospective study.血液系统恶性肿瘤与新型冠状病毒肺炎感染：一项单中心回顾性研究。
Health Sci Rep. 2022 May 22;5(3):e638. doi: 10.1002/hsr2.638. eCollection 2022 May.
9
Clinical Characteristics and Risk Factors of COVID-19 in 60 Adult Cancer Patients.60例成年癌症患者新冠病毒病的临床特征及危险因素
Clin Med Insights Oncol. 2022 Jan 28;16:11795549221074168. doi: 10.1177/11795549221074168. eCollection 2022.
10
Challenges posed by COVID-19 in cancer patients: A narrative review.COVID-19 对癌症患者带来的挑战：一篇叙述性综述。
Cancer Med. 2022 Feb;11(4):1119-1135. doi: 10.1002/cam4.4519. Epub 2021 Dec 23.
本文引用的文献
1
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
2
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
3
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
4
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.血小板与淋巴细胞比值与新型冠状病毒肺炎患者预后相关。
J Med Virol. 2020 Sep;92(9):1533-1541. doi: 10.1002/jmv.25767. Epub 2020 Mar 26.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
7
Risk of COVID-19 for patients with cancer.癌症患者感染新型冠状病毒肺炎的风险。
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
8
Risk of COVID-19 for patients with cancer.癌症患者感染新冠病毒的风险。
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.
9
The outbreak of COVID-19: An overview.COVID-19 疫情概述。
J Chin Med Assoc. 2020 Mar;83(3):217-220. doi: 10.1097/JCMA.0000000000000270.
10
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
Zotero 插件